issued
on 09 Jan 2024
Last Applicant/ Owned by
The Chapleo Building Henry Boot Way
Priory Park, Hull
GB
HU47DY
Serial Number
97751615 filed on 12th Jan 2023
Registration Number
N/A
Correspondent Address
Shauna M. Wertheim
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"BUPRENORPHINE AND NALOXONE", "SUBLINGUAL FILM", and the Schedule III Controlled Substance symbol
"BUPRENORPHINE AND NALOXONE", "SUBLINGUAL FILM", and the Schedule III Controlled Substance symbol Provision of health care advice; providing information relating to opioid dependence Color is not claimed as a feature of the mark. SUBOXONE (BUPRENORPHINE AND NALOXONE) CIII SUBLINGUAL FILM Printed matter, namely, information cards, leaflets and pamphlets in the field of opioid dependence and its Read More
Provision of health care advice; providing information relating to opioid dependence
Printed matter, namely, information cards, leaflets and pamphlets in the field of opioid dependence and its treatment
No 97751615
No Service Mark
No 35197-074T
No
No
No
No
No
No
No
No
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.04 -
Vertical line(s), band(s) or bar(s)
The mark consists of the stylized word "SUBOXONE". The chemical name of the mark "(BUPRENORPHINE AND NALOXONE)" appears underneath the word "SUBOXONE". To the right of the chemical name is a stylized "C" with three vertical lines inside, followed by the words "SUBLINGUAL FILM".
Status Date | Action Taken |
---|---|
09th Jan 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
14th Nov 2023 | PUBLISHED FOR OPPOSITION |
14th Nov 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
25th Oct 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
10th Oct 2023 | EXAMINERS AMENDMENT -WRITTEN |
10th Oct 2023 | EXAMINERS AMENDMENT E-MAILED |
10th Oct 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
10th Oct 2023 | EXAMINER'S AMENDMENT ENTERED |
10th Oct 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
23rd Sep 2023 | ASSIGNED TO EXAMINER |